| CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
6.825 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
DCN |
DCN: Decorin precursor |
6.825 |
Evidence |
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
BID |
BID: BH3-interacting domain death agonist |
6.825 |
Evidence |
|
| CSH2 |
GH1: Somatotropin precursor |
ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
6.825 |
Evidence |
|
| LATS1 |
LATS1, WARTS: Serine/threonine-protein kinase LATS1 |
PLAUR |
PLAUR, MO3, UPAR: Urokinase plasminogen activator surface receptor precursor |
6.825 |
Evidence |
|
| STAM2 |
STAM2: Signal transducing adapter molecule 2 |
MAL2 |
MAL2: Protein MAL2 |
6.825 |
Evidence |
|
| GAS2 |
GAS2: Growth arrest-specific protein 2 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
6.825 |
Evidence |
|
| RASGRP2 |
RASGRP2: RAS guanyl-releasing protein 2 |
RAN |
RAN, ARA24, OK/SW-cl.81: GTP-binding nuclear protein Ran |
6.822 |
Evidence |
|
| CCNB1 |
Cyclin B1 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
6.822 |
Evidence |
|
| HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
HIST2H2BE |
HIST2H2BE, H2BFQ: Histone H2B type 2-E |
6.822 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CNN2 |
CNN2: Calponin-2 |
6.822 |
Evidence |
|
| NAP1L1 |
NAP1L1, NRP: Nucleosome assembly protein 1-like 1 |
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
6.822 |
Evidence |
|
| LIG4 |
LIG4: DNA ligase 4 |
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
6.822 |
Evidence |
|
| TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
6.822 |
Evidence |
|
| TIA1 |
TIA1: Nucleolysin TIA-1 isoform p40 |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
6.822 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
6.822 |
Evidence |
|
| PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
SH3KBP1 |
SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 |
6.822 |
Evidence |
|
| H2AFX |
H2AFX, H2AX: Histone H2A.x |
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
6.822 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
6.822 |
Evidence |
O
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
TIA1 |
TIA1: Nucleolysin TIA-1 isoform p40 |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PRKCQ |
PRKCQ, PRKCT: Protein kinase C theta type |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
CCNB1 |
Cyclin B1 |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
CDK2 |
CDK2: Cell division protein kinase 2 |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
6.822 |
Evidence |
|